<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04924907</url>
  </required_header>
  <id_info>
    <org_study_id>PI20/00321</org_study_id>
    <secondary_id>GRS 2148/B/2020</secondary_id>
    <secondary_id>GRS 2263/B/2020</secondary_id>
    <nct_id>NCT04924907</nct_id>
  </id_info>
  <brief_title>Lifestyles, Arterial Aging and Intestinal Microbiota (MIVAS III Study)</brief_title>
  <official_title>Lifestyles, Arterial Aging and Its Relationship With the Intestinal Microbiota (MIVAS III Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion y Formacion en Ciencias de la Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Castilla-León Health Service</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion para la Investigacion y Formacion en Ciencias de la Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational cross-sectional study whose objective is to analyse associations&#xD;
      between the intestinal and salivate microbiota with lifestyles (eating patterns, physical&#xD;
      activity, tobacco and alcohol consumption), arterial aging and cognitive function. It will&#xD;
      take place in five different research units located in Spain&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: To analyze the association of lifestyles (eating patterns, physical activity, tobacco&#xD;
      and alcohol consumption) with the intestinal and salivate microbiota and its relationship&#xD;
      with arterial aging and cognitive function in subjects without cardiovascular disease in&#xD;
      Spain and Portugal. In addition, the mediating role of the intestinal microbiota in the&#xD;
      relationship of lifestyles with arterial aging and cognitive function will be analyzed.&#xD;
&#xD;
      Design: A cross-sectional study with a case-control analysis, to analyze the association of&#xD;
      microbiota patterns with arterial ageing. Setting: the study will develop the research&#xD;
      network in health prevention and promotion (Rediapp) and in the Iberian network on arterial&#xD;
      structure and the Cancer Research Center of Salamanca. Study population: 800 subjects aged 45&#xD;
      to 74 years without cardiovascular disease, will be selected.&#xD;
&#xD;
      Variables: Demographic, anthropometric and habits (tobacco and alcohol). A dietary pattern&#xD;
      through a frequency consumption questionnaire (FFQ), the software of the EVIDENT III and the&#xD;
      Mediterranean Diet adherence questionnaire. Physical activity: International Physical&#xD;
      Activity Questionnaire (IPAQ), Marshall Questionnaire and Accelerometer, Actigraph. Body&#xD;
      composition (Inbody 230 impedance meter). Arterial aging: Medium intimate carotid thickness&#xD;
      (Sonosite Micromax); Analysis (PWA) and pulse wave velocity (cf-PWV), (Sphygmocor System).&#xD;
      Cardio Ankle Vascular Index (CAVI), ba-PWV and ankle-brachial index (Vasera VS-2000®). With&#xD;
      Ambulatory Pulse Wave Analysis (Microsoft®), the PAIx and CAIx and the heart rate variability&#xD;
      will be measured. The vascular damage in the retina, heart, kidney, brain and cardiovascular&#xD;
      risk will be measured. Intestinal microbiota with the OMNIgene GUT kit (OMR -200) and&#xD;
      analysis of the 16S rRNA microbiome profile by massive sequentiation. (Lifestyles, arterial&#xD;
      aging, neurocognition, microbiota)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pulse Wave Velocity</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement by SphygmoCor System (meters/seg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical Activity</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement by the International Physical Activity Questionnaire (IPAQ) (min/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eating habits</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement by Food Frequency Questionnaire (FFQ) (kcal/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement by a questionnaire of four questions adapted from the WHO MONICA study (Smoking status and cigarettes frequency)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drinking habits</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement by a frequency alcohol questionnaire (units/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement by Inbody 230 device (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carotid intima-media thickness (IMT)</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement by Sonosite Micromax Ultrasound (mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardio Ankle Vascular Index (CAVI)</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement by Vasera device 2000 (not units)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive evaluation</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement by Montreal Cognitive Assessment (MOCA) (points). Range: 0-30 points. A score of 26 points or above is considered normal.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Arterial Stiffness</condition>
  <condition>Dysbiosis</condition>
  <arm_group>
    <arm_group_label>Dysbiosis microbiota</arm_group_label>
    <description>microbiota with proinflammatory pattern or dysbiosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal microbiota</arm_group_label>
    <description>microbiota with antiinflammatory pattern or normal</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects aged 45 to 74 years without cardiovascular disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  People aged 45 to74 years who agree to participate in the study and who not meet any&#xD;
             of the exclusion criteria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants with a personal history of cardiovascular disease (ischaemic heart&#xD;
             disease or stroke, peripheral arterial disease or Heart Failure)&#xD;
&#xD;
          -  Participants with diabetes mellitus 1 or 2&#xD;
&#xD;
          -  Participants with a BMI&gt; 40 kg / m2&#xD;
&#xD;
          -  Participants diagnosed renal failure in terminal stages (GFR &lt;30 ml / min);&#xD;
&#xD;
          -  Chronic intestinal inflammatory disease or acute inflammatory process in the past 3&#xD;
             months&#xD;
&#xD;
          -  Oncology disease diagnosed in the last 5 years or with active treatment&#xD;
&#xD;
          -  Participants who are in a terminal condition&#xD;
&#xD;
          -  Consumption of antibiotics last 15 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis Garcia-Ortiz</last_name>
    <role>Study Director</role>
    <affiliation>Primary Care Research Unit- La Alamedilla Health Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rita Salvado-Martins</last_name>
    <role>Principal Investigator</role>
    <affiliation>Primary Care Research Unit</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pedro Guimaraes-Cunha</last_name>
    <role>Study Director</role>
    <affiliation>Life and Health Sciences Research Institute in Minho University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luis Garcia-Ortiz</last_name>
    <phone>635542886</phone>
    <email>lgarciao@usal.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Primary Care Research Unit (APISAL)</name>
      <address>
        <city>Salamanca</city>
        <zip>37005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Garcia-Ortiz</last_name>
      <phone>635542886</phone>
      <email>lgarciao@usal.es</email>
    </contact>
    <investigator>
      <last_name>Manuel Angel Gómez-Marcos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Lugones-Sánchez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susana González-Sánchez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olaya Tamayo-Morales</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Santos-Minguez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angela de Cabo-Laso</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Agudo-Conde</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jesús Gonzalez-Sanchez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Miguel-Gracia</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rocio Benito-Sanchez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Primary Care Research Unit-Valladolid</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 25, 2021</study_first_submitted>
  <study_first_submitted_qc>June 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2021</study_first_posted>
  <last_update_submitted>June 11, 2021</last_update_submitted>
  <last_update_submitted_qc>June 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lifestyles</keyword>
  <keyword>pulse wave velocity</keyword>
  <keyword>intestinal microbiota</keyword>
  <keyword>multicentric study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysbiosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

